Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism
Hemant Kumar, Hyung-Woo Lim, Sandeep Vasant More, et al.
International Journal of Molecular Sciences (2012) Vol. 13, Iss. 8, pp. 10478-10504
Open Access | Times Cited: 196

Showing 1-25 of 196 citing articles:

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications
Jacek Zielonka, Joy Joseph, Adam Sikora, et al.
Chemical Reviews (2017) Vol. 117, Iss. 15, pp. 10043-10120
Open Access | Times Cited: 1305
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
Chunyan Guo, Li Sun, Xueping Chen, et al.
PubMed (2013) Vol. 8, Iss. 21, pp. 2003-14
Closed Access | Times Cited: 1102
Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury
Marcelo Farina, Daiana Silva Ávila, João Batista Teixeira da Rocha, et al.
Neurochemistry International (2012) Vol. 62, Iss. 5, pp. 575-594
Open Access | Times Cited: 504
Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)
François‐Xavier Theillet, Andrés Binolfi, Tamara Frembgen-Kesner, et al.
Chemical Reviews (2014) Vol. 114, Iss. 13, pp. 6661-6714
Open Access | Times Cited: 454
Glutathione metabolism and Parkinson's disease
Michelle Smeyne, Richard J. Smeyne
Free Radical Biology and Medicine (2013) Vol. 62, pp. 13-25
Open Access | Times Cited: 393
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress
Hugo Juárez Olguı́n, David Calderón Guzmán, Ernestina Hernández García, et al.
Oxidative Medicine and Cellular Longevity (2015) Vol. 2016, Iss. 1
Open Access | Times Cited: 366
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases
Hemant Kumar, In‐Su Kim, Sandeep Vasant More, et al.
Natural Product Reports (2013) Vol. 31, Iss. 1, pp. 109-139
Closed Access | Times Cited: 316
The role of Nrf2 signaling in counteracting neurodegenerative diseases
Albena T. Dinkova‐Kostova, Rumen V. Kostov, Aleksey Kazantsev
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3576-3590
Open Access | Times Cited: 285
A Review on Free Radicals and Antioxidants
Hourieh Alkadi
Infectious Disorders - Drug Targets (2018) Vol. 20, Iss. 1, pp. 16-26
Closed Access | Times Cited: 273
Role of Nrf2 and Its Activators in Respiratory Diseases
Qinmei Liu, Yun Gao, Xinxin Ci
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-17
Open Access | Times Cited: 249
Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer’s Disease
Alessandro Pinto, Alessio Bonucci, Elisa Maggi, et al.
Antioxidants (2018) Vol. 7, Iss. 5, pp. 63-63
Open Access | Times Cited: 213
Neuroprotective Activities of Curcumin in Parkinson’s Disease: A Review of the Literature
Eslam El Nebrisi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11248-11248
Open Access | Times Cited: 116
Mitochondrial Oxidative Stress and “Mito-Inflammation”: Actors in the Diseases
Simone Patergnani, Esmaa Bouhamida, Laura S. Leo, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 216-216
Open Access | Times Cited: 108
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 66
The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation
Mohammad Sobhan Karvandi, Farzam Sheikhzadeh Hesari, Amir Reza Aref, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 47
The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease
Li Zuo, Michael S. Motherwell
Gene (2013) Vol. 532, Iss. 1, pp. 18-23
Closed Access | Times Cited: 184
Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?
Hemant Kumar, Dong‐Kug Choi
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 160
Oxidative stress and neurodegeneration: the involvement of iron
Alessia Carocci, Alessia Catalano, Maria Stefania Sinicropi, et al.
BioMetals (2018) Vol. 31, Iss. 5, pp. 715-735
Closed Access | Times Cited: 154
Mitochondrial Dysfunction: A Basic Mechanism in Inflammation-Related Non-Communicable Diseases and Therapeutic Opportunities
Anna Hernández‐Aguilera, Anna Rull, Esther Rodríguez‐Gallego, et al.
Mediators of Inflammation (2013) Vol. 2013, pp. 1-13
Open Access | Times Cited: 144
Protective Mechanisms of Flavonoids in Parkinson’s Disease
Kasthuri Bai Magalingam, Ammu Kutty Radhakrishnan, Nagaraja Haleagrahara
Oxidative Medicine and Cellular Longevity (2015) Vol. 2015, pp. 1-14
Open Access | Times Cited: 131
SOD1 and DJ-1 Converge at Nrf2 Pathway: A Clue for Antioxidant Therapeutic Potential in Neurodegeneration
Pamela Milani, Giulia Ambrosi, Omar Gammoh, et al.
Oxidative Medicine and Cellular Longevity (2013) Vol. 2013, pp. 1-12
Open Access | Times Cited: 122
Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson’s Disease Model
Hemant Kumar, In‐Su Kim, Sandeep Vasant More, et al.
Evidence-based Complementary and Alternative Medicine (2013) Vol. 2013, pp. 1-13
Open Access | Times Cited: 120
Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease
Sean Hong Tan, Venkatanaidu Karri, Nicole Wuen Rong Tay, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 765-777
Open Access | Times Cited: 119
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease models
Palanivel Ganesan, Hyun-Myung Ko, In‐Su Kim, et al.
International Journal of Nanomedicine (2015), pp. 6757-6757
Open Access | Times Cited: 108
Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty
Çağlar Coşarderelioğlu, Lolita S. Nidadavolu, Claudene J. George, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 108
Page 1 - Next Page

Scroll to top